2.2.0.25truefalse41602 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Changes in the Carrying Amount of Goodwill by Segment) (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse12/31/2010
USD ($)
USD ($) / shares
$As_Of_12_31_2010http://www.sec.gov/CIK0000014272instant2010-12-31T00:00:000001-01-01T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse12/31/2009
USD ($)
USD ($) / shares
$As_Of_12_31_2009http://www.sec.gov/CIK0000014272instant2009-12-31T00:00:000001-01-01T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit12Divide
http://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse12/31/2008
USD ($)
$As_Of_12_31_2008http://www.sec.gov/CIK0000014272instant2008-12-31T00:00:000001-01-01T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : BioPharmaceuticals [Member]
12/31/2010
USD ($)
$As_Of_12_31_20103166http://www.sec.gov/CIK0000014272instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseBioPharmaceuticals [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BiopharmaceuticalsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : BioPharmaceuticals [Member]
12/31/2009
USD ($)
$As_Of_12_31_20097246http://www.sec.gov/CIK0000014272instant2009-12-31T00:00:000001-01-01T00:00:00falsefalseBioPharmaceuticals [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BiopharmaceuticalsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : BioPharmaceuticals [Member]
12/31/2008
USD ($)
$As_Of_12_31_200827http://www.sec.gov/CIK0000014272instant2008-12-31T00:00:000001-01-01T00:00:00falsefalseBioPharmaceuticals [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BiopharmaceuticalsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : BioPharmaceuticals [Member]
{dei_LegalEntityAxis} : ZymoGenetics Acquisition [Member]
1/1/2010 - 12/31/2010
USD ($)
$Duration_1_1_2010_To_12_31_20102299http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseBioPharmaceuticals [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BiopharmaceuticalsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : BioPharmaceuticals [Member]
{dei_LegalEntityAxis} : Medarex Acquisition [Member]
1/1/2009 - 12/31/2009
USD ($)
$Duration_1_1_2009_To_12_31_20092277http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseBioPharmaceuticals [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_BiopharmaceuticalsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseMedarex Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_MedarexAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Other Segment [Member]
12/31/2008
USD ($)
$As_Of_12_31_200828http://www.sec.gov/CIK0000014272instant2008-12-31T00:00:000001-01-01T00:00:00falsefalseOther Segment [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_OtherSegmentsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217US
Diso42170USDUSD$10falsefalseUSDtruefalse{us-gaap_StatementBusinessSegmentsAxis} : Other Segment [Member]
{dei_LegalEntityAxis} : Mead Johnson Split-off Distributions [Member]
1/1/2009 - 12/31/2009
USD ($)
$Duration_1_1_2009_To_12_31_20092278http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseOther Segment [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldibmy_OtherSegmentsMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberfalsefalseMead Johnson Split-off Distributions [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_MeadJohnsonSplitoffDistributionsMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false12falsefalseUSDtruefalse{dei_LegalEntityAxis} : ZymoGenetics Acquisition [Member]
1/1/2010 - 12/31/2010
USD ($)
$Duration_1_1_2010_To_12_31_20102298http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseZymoGenetics Acquisition [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_ZymogeneticsAcquisitionMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.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:monetaryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 43
falsefalse3false0us-gaap_GoodwillAcquiredDuringPeriodus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7truefalsefalse
1500000015falsefalsefalsetruefalse8truefalsefalse508000000508falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11truefalsef
alse508000000508falsefalsefalsetruefalse12truefalsefalse1500000015falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e(1)
falsefalse4false0us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnitus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1falsefal
sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10truefalsefalse-117000000-117falsetruefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalseMonetaryxbr
li:monetaryItemTypemonetaryWrite-off of the carrying amount of goodwill associated with all or a portion of a reporting unit that is sold in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 142
-Paragraph 45
-Subparagraph e(3)
falsefalse123GOODWILL AND OTHER INTANGIBLE ASSETS (Changes in the Carrying Amount of Goodwill by Segment) (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue
